⌘K

Login Start Free

Home/Filings/4/0001493152-19-009915

4//SEC Filing

Yeaton Howard 4

Accession 0001493152-19-009915

CIK 0001321834other

View on SEC.gov Company Profile

Filed

Jun 27, 8:00 PM ET

Accepted

Jun 28, 6:05 PM ET

Size

4.4 KB

Accession

0001493152-19-009915

Insider Transaction Report

Form 4

Period: 2019-06-28

Akers Biosciences, Inc.AKER

CEO, CFO

Transactions

Award
Common Stock
2019-06-28$0.45/sh+3,750$1,695→ 33,750 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

Akers Biosciences, Inc.

CIK 0001321834

Entity typeother

Related Parties

1

filerCIK 0001341910

Filing Metadata

Form type: 4
Filed: Jun 27, 8:00 PM ET
Accepted: Jun 28, 6:05 PM ET
Size: 4.4 KB

View on SEC.gov